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Background: Methicillin-resistant Staphylococcus aureus (MRSA)-USA300 is notorious for its ability to cause
community- and healthcare-acquired infections, which are even more difficult to treat when associated with a
biofilm phenotype. We aimed to characterize the genetic determinants of biofilm formation in a USA300 skin
abscess isolate (UAS391) that formed prolific biofilms.
Methods: USA300 S. aureus strains, TCH1516 and FPR3757, were found to be closely related based on whole
genome mapping (Argus™ Optical Mapping System, Opgen Inc, Gaithersburg, USA) to UAS391 (96.3-99.1 %
similarity, P=0.0151), however differed markedly in biofilm formation (P=0.0001) on a dynamic assay (BioFlux 200,
Fluxion Biosciences, USA). Comparison of whole genome sequences of these strains identified differences in a total
of 18 genes. Corresponding Tn (bursa aurealis-bearing) knockout mutants in these target genes were obtained from
a publicly available mutant library of the same clonal lineage (USA300-JE2) and were characterized phenotypically
for biofilm formation. Tn mutants showing significant differences in biofilm formation were utilized for
transduction into a plasmid-cured erythromycin-sensitive derivative of UAS391 and for complementation
experiments. All strains were tested on the dynamic assay, and 17h-biofilms were stained (SYTO9, Life Technologies)
and fluorescence intensity quantified by microscopy (Zeiss, ImageJ). Gene expression levels in Tn and transduced
mutants were studied by quantitative reverse transcriptase PCR (StepOnePlusTM, Applied Biosystems®).
Results: Comparison of the sequenced genomes of TCH1516, FPR3757 and UAS391 yielded a limited number of
variant genes (n=18) that were hypothesized to account for the observed difference in biofilm-forming capacity.
Screening of Tn mutants disrupted in these target genes identified one mutant (NE229) bearing a transposon
insertion in SAUSA300_1119 (fakA), which exhibited increased biofilm formation similar to UAS391 (P=0.9320).
Transduction experiments confirmed that fakA::Tn corresponded to 1.9- to 4.6-fold increase in biofilm formation
depending on the USA300 strain background (P≤0.0007), while complementation of the TCH1516 wild-type fakA
allele in UAS391 resulted in a 4.3-fold reduction in biofilm formation (P<0.0001).
Conclusions: This sequential approach, consisting of strain typing, genome comparison and functional genomics,
identified fakA, a recently described fatty acid kinase in S. aureus that is essential for phospholipid synthesis and also
impacts the transcription of numerous virulence factors, as a negative regulator of biofilm formation in S. aureus USA300.
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Staphylococcus aureus causes infections ranging from
minor skin infections to life-threatening diseases, such
as pneumonia, meningitis, osteomyelitis, endocarditis,
and septicaemia. Since their emergence in the 1960s,
methicillin-resistant S. aureus have become one of the
major causes of hospital-acquired (HA) infections such
as implant-associated and postsurgical wound infections,
as well as of community-acquired (CA) infections such
as pneumonia. The success of these hospital-acquired
MRSA (HA-MRSA) clones can be partly attributed to
virulence-specific factors, such as extracellular toxins,
surface structures facilitating tissue colonization, im-
mune evasion and tissue destruction [1], as well as to
prolonged persistence of MRSA infections linked to the
formation of biofilms in vivo [2].
It is generally accepted that biofilms, comprising con-
glomerations of cells attached to a solid support and em-
bedded in a matrix of extracellular polymers, represent a
major problem in clinical practice, due to their forma-
tion on implanted medical devices [3] and their intrinsic
enhanced resistance to antibiotics that are otherwise effi-
cacious against the bacterium’s planktonic life forms [4].
These biofilm-associated complications have triggered
the search for potential genes and/or metabolic path-
ways, interruption of which could represent new thera-
peutic or preventive interventions specifically targeting
this bacterial life-style. Functional genomics approaches
such as transcriptomics and proteomics, performed on
biofilm versus planktonic cells, have shed some light on
the complexity of the biofilm phenotype in S. aureus.
Among genes found to be up-regulated in biofilm cells
were those encoding proteins involved in the synthesis
of polysaccharide intercellular adhesin (PIA)/ polymeric
N-acetyl-glucosamine (PNAG) as well as proteins medi-
ating transport, amino acid metabolism and translation,
with many other up-regulated genes encoding hypothet-
ical proteins of still unknown function [5]. Subsequent
proteomic studies performed by Resch et al. [6] showed
still more stringently that biofilm-induced proteins are
involved in cell attachment and peptidoglycan synthesis,
in pyruvate and formate metabolism, as well as in regu-
latory processes, in particular those exerted by the
staphylococcal accessory regulator A protein.
We recently screened a large collection of clinically
important MRSA isolates for their ability to form bio-
films, and subsequently typed these isolates [7]. This
work yielded a number of strong biofilm-forming strains,
with three of them belonging to the USA300 clonal
lineage, one of which was selected for genome sequen-
cing. Subsequent comparison of the strain’s genome with
those of other USA300 sequenced isolates revealed a
particularly interesting pair of closely related USA300
strains showing notably different capacities for biofilmformation (UAS391 and USA300_TCH516). This finding
offered the opportunity to search in clinical isolates at
genome level for mechanisms of biofilm formation.
Thus, various USA300 S. aureus clones, which are
closely related as per whole genome mapping, but mark-
edly different in biofilm formation, were compared at
genome level and consequently genetic loci with differ-
ent alleles were identified. Corresponding knockout mu-
tants of these genes, obtained from a publically available
mutant library of the same clonal lineage (USA300-JE2),
were then phenotypically characterized for their poten-
tial role in biofilm formation. Transposon-mediated
interruption of one of the tested divergent genes,
SAUSA300_1119, corresponding to the gene fakA, re-
sulted in drastically increased levels of biofilms as com-
pared to the parental control strain JE2, marking this
gene as an important determinant of biofilm formation.
These results shed more light on the genetic factors
regulating biofilm formation in S. aureus.
Methods
Bacterial strains and growth conditions
USA300 strains used for clonal, genomic, and pheno-
typic analyses are listed in Table 1. Tn insertion mutants
used for genotypic and phenotypic analysis of biofilm
formation, were obtained from a sequence-defined trans-
poson mutant library consisting of 1,952 strains, each
containing a single mutation within a nonessential gene
in strain USA300 JE2 [8] obtained from the NARSA re-
pository (www.beiresources.org/). S. aureus USA300
FPR3757 (FPR3757) and USA300 JE2 (JE2) were also ob-
tained from the NARSA repository. Strains UAS391,
TCH1516, FPR3757 and JE2 were routinely grown on
brain heart infusion (BHI) and lysogeny broth (LB)
medium for biofilm and transduction experiments, re-
spectively. Transposon insertion mutants were grown on
BHI medium containing 10 μg/ml of erythromycin
(Sigma-Aldrich).
Transduction experiments
Transduction was performed essentially as described [9].
Transducing phage ϕ11 was obtained from the super-
natant of a culture of the lysogenic S. aureus strain
RN0451 (NARSA strain NRS136) and propagated on S.
aureus RN0450 (NARSA strain NRS135) by standard
techniques [10]. A transducing phage stock was pre-
pared by infection at 37 °C of S. aureus containing the
bursa aurealis transposon insertion. After infection of
cultures of the recipient S. aureus strains (UAS391 and
TCH1516) with this stock, transductants were selected
on LB plates with 0.05 % sodium citrate containing
5 mg/L erythromycin at 37 °C. The resulting colonies
were purified at least twice on the same medium to en-
sure loss of the transducing phage.
Table 1 Strains and plasmids used for clonal, genomic, and phenotypic analyses during this study
Strains/Plasmids Description Source
Strains
UA S391 S. aureus strain USA_UAS391 [18]
JE2 S. aureus USA300 parental strain for the NARSA transpos on library NARSAa
FPR3757 S. aureus USA300_FPR3757 NARSA
TCH1516 S. aureus subsp. aureus USA300_TCH1516 ATCC
UA S391-Erys Heat-cured erythromycin-sensitive derive of UAS391 This study
TCH1516-Erys Heat-cured erythromycin-sensitive derive of TCH1516 This study
UA S391-NE229 UA S391-Erys transductant with mutation in EX97_05885 This study
TCH1516-NE229 TCH1516-Erys transductant with mutation in USA 300Hou_1162 This study
NE229-pHD954 S. aureus stra NE229 completed with pHD954 This study
NE229-pHD957 S. aureus strain NE229 completed with pHD957 This study
UA S391-pHD957 S. aureus strain UA S391 completed with pHD957 This study
RN0451 Phage Φ11 lysogenic S. aureus strain (NARSA strain NRS 136) NARSA
RN0450 S. aureus RN0450 (NARSA strain NRS 135) NARSA
RN4220 Restriction-deficient intermediate S. aureus cloning host RN4420 NARSA
Restriction-deficient intermediate S. aureus cloning host RN4420 NARSA
NE1646 Transposon mutant with insertion in USA200HOU_0155 (SA USA300_0145) NARSA
NE229 Transpos on mutant with insertion in USA300HOU_1162 (SA USA300_1119) NARSA
NE1081 Transpo on mutant with insertion in USA300HOU_2626 (SA USA300_2561) NARSA
NE454 Transpo on mutant with insertion in USA300HOU_2631 (SA USA300_2566) NARSA
NE1290 Transposon mutant with insertion USA300HOU_2641 (SA USA300_2576) NARSA
NE81 Transposon mutant with insertion in USA300HOU_2319 (SA USA300_2285) NARSA
NE1036 Transposon mutant with insertion in USA300HOU_2602 (SA USA300_2542) NARSA
NE1038 Transposon mutant with insertion in USA300HOU_2678 (SA USA300_2610) NARSA
NE33 Transposon mutant with insertion in USA300HOU_2654 (SA USA300_2589) NARSA
NE1262 Transposon mutant with insertion in USA300HOU_2026 (SA USA300_1984) NARSA
NE1875 Transposon mutant with insertion in USA300HOU_1934 (SA USA300_1918) NARSA
NE1 Transposon mutant with insertion in USA300HOU_1372 (SaA USA300_1327) NARSA
NE334 Transposon mutant with insertion in USA300HOU_2197 (SA USA300_2161) NARSA
NE809 Transposon mutant with insertion in USA300HOU_1260 (SA USA300_1214) NARSA
NE1403 Transposon mutant with insertion in USA300HOU_1260 (SA USA300_1585) NARSA
NE1026 Transposon mutant with insertion in USA 300HOU_1338 (SA USA 300_1298) NARSA
NE1314 Transposon mutant with insertion in USA300HOU_0953(SA USA300_0896) NARSA
Plasmids
pALC2073 Shuttle vector pALC2073 [11]
pHD954 pALC2073 with cloned fakA gene amplifie from UAS391 This study
pHD957 pALC2073 with cloned fakA gene amplifie from TCH15116 This study
aThis library now exists at www.beiresources.org and is discussed by Fey et al. [8]
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To complement the S. aureus mutant strain NE229, total
genomic DNA of strains UAS391 and TCH1516 was
purified with the Quick Pick™ SML gDNA kit (BN Prod-
ucts & Services) according to the manufacturer’s recom-
mendations. S. aureus strains were lysed by adding 5 μg
lysostaphin (Sigma-Aldrich). The genes corresponding toSAUSA300_1119 from the S. aureus strains UAS391 and
TCH1516 were amplified using ExTaq DNA polymerase
(Takara) with the primer pair Glyk-1 (5’-TACCGAGCTC-
GAATTCTAGGAGGACAACTTGAAATGATTAG-3’) and
Glyk-2 (5’-GACGGCCAGTGAATTCATTTTTATTCTACT-
GAAAAGAAATATTG-3’). Polymerase chain reactions
(PCR) were carried out in an Applied Biosystems 2720
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ing and elongation temperatures were 55 °C and 68 °C
respectively, with an elongation time of 1 min per 1000 bp.
during 30 cycles. PCR-fragments were purified using the
Qiaquick PCR Purification Kit (Qiagen GmbH) and ana-
lysed by gel electrophoresis on 1.0 % agarose gels. The
resulting 1753 bp. PCR fragments were cloned by the
InFusion technique (Clontech Laboratories, Inc) in the
EcoRI site of the shuttle vector pALC2073 [11] yielding the
plasmids pHD954 (UAS391) and pHD957 (TCH1516).
DNA sequencing was performed at the VIB core sequen-
cing facility (VIB Genetics Department, University of
Antwerp) using the pALC2073 vector primers TetR2
(5’-CAATGTAGGCTGCTCTACACCTAG-3’), pALC-2 (5’-
GATCGGTGCGGGCCTCTTCGCTAT-3’), and the internal
gene sequence primers Glyk-3 (5’-GGAGTACATTATTG-
TAAAAGCCAATGAATC-3’) and Glyk-4 (5’- CCACACA-
TATCATTAGTGGTGGACA-3’). These plasmids were
transferred into the restriction-deficient intermediate S.
aureus cloning host RN4220 to adapt the plasmid DNA
[12] to the S. aureus modifications. Transformants were se-
lected on LB plates supplemented with 10 μg/ml chloram-
phenicol (Sigma-Aldrich). The plasmids pHD954 and
pHD957 were isolated from the RN4220 strain and used to
transform strain NE229. UAS391 was also complemented
with the wild-type fakA allele carried on pHD957.
RNA extraction and RT-PCR
Mutant strain NE229 and wild-type strains FPR3757 and
JE2 were grown as overnight cultures in 10 ml of BHI
medium at 37 °C with shaking. Total RNA of the three
bacterial strains was extracted after 16 h growth using Ex-
press Amptec kit (Ambion). Two μg of RNA was treated
with DNase using the Turbo DNA-free™ Kit (Ambion® by
Life Technologies™) and subsequently used for reverse
transcription reaction using the Reverse Transcription
System (Promega) with random primers according to the
manufacturer’s instructions. Real-time PCR was per-
formed using a StepOnePlus™ system (Applied Biosys-
tems®) in a 20 μl reaction mixture with Absolute Blue
qPCR SYBR green ROX mix (Thermo Scientific, Inc). For
RT-PCR analysis, the cDNA samples were amplified with
gene-specific primers 1162 F (5’-ATGATGTGGACG-
CAACACTTG-3’) and 1162Rev (5’-AATCAAGCCCA-
TAAACGCGTC-3’), in duplicate. Cycling conditions were
95 °C for 10 min, and 40 cycles of 95 °C for 15 s and 60 °C
for 60 s and 72 °C for 40 s. Amplification plot and melting
curve were analysed for the dynamics of fluorescence and
specificity of amplification, correspondingly. Resulting
PCR products were checked by gel electrophoresis.
Whole genome mapping
For WGM, UAS391 and TCH1516 were grown on BHI
plates, and high molecular weight DNA was extractedfrom the overnight colonies using Argus® HMW DNA
extraction kit (Opgen, Inc). Following DNA extraction
as recommended by manufactures protocol, DNA mole-
cules were loaded on a MapCard surface (Opgen, Inc)
where single DNA molecules were immobilized and lin-
earized. The linearized DNAs were subjected to in situ
digestion with NcoI (Opgen, Inc). Following digestion,
the DNA molecules were stained with the fluorescent
intercalating agent JoJo-1 forming part of the staining kit
(Opgen, Inc). The digested and stained DNA fragments
were imaged and assembled by in built assembler of
Map Manager to produce whole genome restriction
maps, as described previously [13]. Finally, derived
whole genome maps were analysed using BioNumerics
v7.5. (Applied Maths, Belgium).
Genome sequencing
The complete genome sequence of UAS391 was gener-
ated by using the Illumina HiSeq2000 platform, as de-
scribed previously [14]. Sequence data of UAS391 were
de novo assembled using Velvet [15] and SPAdes [16].
Assembled contigs were ordered against the UAS391
whole genome map using MapSolver software (Opgen,
Inc). Validated scaffolds were ordered against published
S. aureus genome TCH1516 (accession no. CP000730),
and the generated pseudo chromosome was compared
to the genomes of TCH1516 and FPR3757 (accession
no. CP000255.1) using Mauve v2.3.1 [17]. Similarly, we
also performed reference assembly independently by
using the genome sequences of TCH1516 and FPR3757
as references, and SNPs were extracted in CLC Genom-
ics Workbench 7.5.1 (QIAGEN, Aarhus A/S, Denmark).
The assembled chromosome of UAS391 was annotated
as described [18]. Multiple alignment and phylogenetic
analysis were performed using MEGA6 [19].
Flow biofilm assay and quantification of biofilm mass
A medium-throughput continuous flow system BioFlux
200 (Fluxion Biosciences, USA) was used to study bio-
film formation under shear flow conditions, which
mimics flow conditions of physiological liquids in the
human body [20]. BHI or 0.5xBHI with 0.1 % glucose
was used to feed into the flow cell. Bacterial cultures at
0.05 MacFarland were then used to inoculate the output
wells; bacteria were pushed through the flow cell from
the output well up to the horizontal microfluidic chan-
nel by reversing the flow and were allowed to attach for
one hour followed by 16 h of incubation at 37 °C in BHI
or 0.5xBHI with 0.1 % glucose at a flow rate of 0.5 dyne/
cm2. Biomass in the microfluidic channels was stained
with SYTO 9 fluorescent stain (Invitrogen, Life Tech-
nologies). Biofilm images were captured employing ZEN
2012 software (Zeiss) as combined tile images consisting
of 81 one μm2 horizontal tiles covering the entire
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corded as integrated density on the entire combined tile
image using Image J freeware (http://imagej.nih.gov/)
using “integrated density”, “mean value” and “area” as
measurement settings. Presented values are averages of
three independent combined tile images.Statistical analysis
Statistical analysis of biomass formation in the dynamic
flow assay was performed using the R Project software
(version 3.1.2.). The influence of a particular gene inter-
ruption on biofilm formation and the comparison of the
space occupied by the cells within the dynamic biofilms
were analysed using a pairwise one-way ANOVA,
Shapiro-Wilk normality testing, Bartlett’s test of variances,
and Tukey’s honest significance difference testing. Results
from RT-PCR were analysed through a Wilcoxon signed-
rank test. P < 0.05 were considered to be significant.Results
Typing and phenotypic analysis of USA300 isolates
Whole genome mapping (WGM) allowed typing and
grouping of strain UAS391 with sepsis strain
USA300_TCH1516 (TCH1516) isolated at Texas Chil-
dren’s Hospital in Houston [21] along with two other S.
aureus USA300 strains, USA300-FPR3757 (FPR3757)
and its plasmid-cured laboratory derivative USA300-JE2
(JE2), both belonging to the USA300 clonal lineage. Ac-
cording to the WGM similarity cut-off recently estab-
lished for USA300 isolates [22], a WGM-based clonal
cluster is defined as a set of isolates having a whole gen-
ome map similarity of >95 %, which assigned all four
isolates discussed here to the same WGM clonal cluster
(Fig. 1). As UAS391 was previously identified as a prolific
biofilm former [7], we directly compared its biofilm form-
ing capacity to the other clonally related strains in a dy-
namic biofilm assay. Comparison of UAS391 with the
other USA300 isolates in this dynamic biofilm model con-
sistently revealed clear differences in this strain’s ability to
form biofilms under these conditions, with UAS391 form-
ing 1.6- to 3.6-fold more biofilm than the other three
USA300 strains, as measured by readout of fluorescence
(P < 0.0001, ANOVA, F = 56.95, df = 3) (Fig. 2).Fig. 1 Whole genome maps of USA300 strains. Green lines indicate identit
represent the variationsIdentifying potential gene targets by comparative
genomics
Genomic divergence between phenotypically diverse
strains from the USA300 clonal lineage should by defin-
ition be very limited [21, 23]. Since TCH1516 was closely
related to UAS391 as per WGM and its total genome se-
quence is already available [21], we reasoned that com-
paring the whole genome sequences of UAS391 and
TCH1516 would likely yield genetic differences that
could account for the observed differences in the biofilm
phenotype between these two USA300 strains. We thus
sequenced the UAS391 genome by using the Illumina
HiSeq2000 platform [18], and identified a total of 52
gene loci where UAS391 and TCH1516 exhibited single
nucleotide polymorphisms (SNPs) (Additional file 1:
Table S1), of which 47 mapped within open reading
frames (ORFs) and 5 within intergenic regions.
Based on genome sequence data and comparison of
whole genome maps (Fig. 1), FPR3757 is closely related
to TCH1516 [24], and thus also to UAS391, and forms
less biofilms in the dynamic biofilm model, compared to
UAS391 (P = 0.0172) and similar to TCH1516 (Fig. 2)
(P = 1.0000). As the complete sequence for FPR3757 is
also available, we then compared UAS391 and FPR3757
and identified a total of 91 gene loci where UAS391 and
FPR3757 exhibited SNPs (Additional file 2: Table S2), of
which 60 mapped within ORFs and 31 within intergenic
regions. To further narrow down this initial list of devi-
ating genes, we identified an overlap between the gene
alleles of UAS391, TCH1516 and FPR3757 (Additional
file 1: Table S1 and Additional file 2: Table S2). This re-
duced the initial list of genetic variations between strains
UAS391 and TCH1516 to only those SNPs that were
identical in the two weak biofilm forming strains
TCH1516 and FPR3757 but different in UAS391, poten-
tially identifying those SNPs primarily responsible for
the increased biofilm formation in UAS391. This com-
parison yielded 18 SNPs as shown in Table 2. Of this,
SNPs in transposases and phage-elements (USA300-
HOU_0286 and 1488) were excluded from further ana-
lysis (n = 2).
Similarly, comparative genome alignment was performed
for TCH1516, FPR3757 and UAS391 to confirm the data
obtained by whole genome sequencing (Additional file 3:
Figure S1).y of restriction pattern among the maps and red horizontal marks
ab
Fig. 2 Biofilm formation of USA300 strains in the dynamic shear flow assay. Quantification (a) and visualization (b) of biofilms formed by
wild-type USA300 strains and corresponding derivate strains
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using gene knockout mutants
In order to investigate the role of the corresponding
genes in biofilm formation, we obtained 12 mutants
from the Network on Antimicrobial Resistance in S. aur-
eus (NARSA) library in which transposon insertions
map in genes affected by SNPs, belonging to the above
identified group of 16 genes enumerated in Table 2. For
the remaining four candidate genes, USA300HOU_0521,
1051, 1166, and 0502, corresponding knockout mutants
were not present in the library and these were not stud-
ied further. We also randomly selected five genes af-
fected by SNPs solely in either TCH1516 or FPR3757 incomparison to UAS391. In total, the 17 mutants ob-
tained from the NARSA library (corresponding to
USA300HOU_ 0953, 0155, 1162, 1260, 1372, 2197,
2626, 2631, 2641, 2319, 2602, 2678, 2654, 1626, 2026,
1338, 1943) were phenotypically tested in duplicate for
their ability to form flow biofilms using the library par-
ental strain JE2 as the corresponding control. Significant
positive and negative variations of the degree of biofilm
formation as compared to JE2 were found (P = 0.0018,
ANOVA, F = 4.44, df = 17). Out of the 17 mutants tested
(Fig. 3), one mutant NE229 showed a 2-fold increase in
biofilm formation compared to JE2 (P = 0.0024). NE229
harbours the transposon insertion at position 393 in
Table 2 Single nucleotide polymorphisms (SNPs) between TCH1516/FPR3757 and UAS391. Consensus base represents TCH1516 and
FPR3757, allele represents a corresponding base in UAS391. Predicted amino acid changes in UAS391 compared to TCH1516 and







Predicted amino acid change
(TCH1516/FPR3757)










Met386Ile gtlX: glutamyl-tRNA synthetase
A C USA300HOU_1051/
SAUSA300_1013
Asn267Thr/Asn263Thr Bacterial cell division membrane protein FtsW
A G USA300HOU_1162/
SAUSA300_1119
Glu524Gly fakA: Fatty acid kinase
G T USA300HOU_1166/
SAUSA300_1123




Val1114Ala Ebh: Cell Wall-Associated Fibronectin-Binding Protein
C A USA300HOU_2197/
SAUSA300_2161
Hyaluronate lyase is a glycosaminoglycan (GAG)
polysaccharide lyase family. This family consists of a
group of secreted bacterial lyase enzymes capable of
acting on glycosaminoglycans, such as hyaluronan and
chondroitin, in the extracellular matrix of host tissues,
contributing to the invasive capacity of the pathogen.
G A USA300HOU_2631/
SAUSA300_2566




PTS system, fructose-specific II ABC component, multi











Ser1782Ala Serine-rich adhesin for platelets, cell surface protein
precursor; KxYKxGKxW signal peptide
C T USA300HOU_0502/
SAUSA300_0486
Thr85Met Uncharacterized protein YabR
C T USA300HOU_1626/
SAUSA300_1585
Ser35Leu tRNA threonylcarbamoyladenosine dehydratase (Cells
lacking this gene have a normal growth phenotype,
but are unable to survive in a competitive growth
situation with the wild-type strain. They display only
the t6A but not the ct6A modification in tRNAs, and
have lower decoding efficiency than wild-type. They
show no defects in antibiotic sensitivity. In growth
competition experiments, a tcdA mutant shows reduced










Phe130fs2 5-bromo-4-chloroindolyl phosphate hydrolysis protein
1The symbol (*) refers to the predicted amino acid change as a stopcodon caused by the corresponding SNP
2The abbreviation (fs) refers to ‘frame shift mutation’
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Fig. 3 Biofilm formation of USA300 strains in the dynamic shear flow assay. Quantification (a) and visualization (b) of biofilms formed by JE2 and
its transposon mutants
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fakA located in the genome from position 1223940 to
1225586 nt [25] (Additional file 4: Figure S2).
Reverse transcription PCR (RT-PCR) was performed to
determine whether the bursa aurealis insertion had affected
transcription of SAUSA300_1119. Primers were designed
downstream of the transposon mutation. Transcription of
SAUSA300_1119 in NE229 showed a significant decreasecompared to that in wild-type strains FPR3757 and JE2
(Cts of 31.9, 26.2, and 26.0, respectively) (P < 0.0001,
ANOVA, F = 1599.54, df = 6). Similar decrease in transcrip-
tion was also observed for the TCH1516-EryS and the
UAS391-EryS strain transduced with the SAUSA300_1119
mutated allele from NE229 (P < 0.0001) (Fig. 4).
The SAUSA300_1119 in UAS391 harbours a non-syn-
onymous SNP (Glu524Gly) as compared to strains
Fig. 4 Transcription levels of the fakA gene in UAS391, TCH1516, FPR3757, JE2 and in corresponding transductant strains. Transcription levels of
fakA were measured in duplicate by real-time RT-PCR and expressed as an amplification plot and Ct mean values
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fied it as a unique SNP and it can thus be considered as
the mutant version of the corresponding gene present in
TCH1516 and FPR3757, with similar wild-type alleles
being present among other sequenced S. aureus isolates
(Additional file 4: Figure S2).
Transductants mutated in fakA gene exhibit elevated
biofilm formation
In order to further corroborate the negative role of fakA
in biofilm formation by USA300, the knockout mutation
in gene SAUSA300_1119 was transferred from NE229
into both UAS391-EryS and TCH1516-EryS employing
phage-mediated transduction resulting in UAS391-
NE229 and TCH1516-NE229, respectively. Knocking out
SAUSA300_1119 in TCH1516 (locus tag USA300-
HOU_1162) resulted in a 1.7-fold increase in biofilm
formation compared to the wild type TCH1516(P = 0.0007), and at levels similar to the wild-type UAS391
(P = 0.9710) (Fig. 2). This effect was also observed in the
UAS391 background where UAS391-NE229 exhibited
even more abundant biofilm formation than the wild-type
UAS391 (P = 0.0510) (Fig. 2).
A plasmid-borne copy of the wild-type fakA gene
complements the mutant phenotype
In order to unambiguously prove that the enhanced bio-
film phenotype observed in the NE229 strain is indeed
due to the knockout mutation of the fakA gene, the mu-
tant strain was complemented with a plasmid-borne in-
tact fakA allele present in the TCH1516 strain or with
the corresponding SNP-containing allele present in the
UAS391 strain, yielding NE229-pHD957 and NE229-
pHD954 strains, respectively. As shown in Fig. 2, the
amount of biofilm produced by NE229-pHD957 was
2.9-fold lower as compared to NE229 (P = 0.0003), and
Sabirova et al. BMC Genomics  (2015) 16:861 Page 10 of 12similar to the amount of biofilm produced by the parent
JE2 strain (P = 0.9831), whereas the amount of biofilm
produced by NE229-pHD954, containing only mutant
fakA allele was the same as in NE229 (P = 1.0000). Add-
itionally, complementing UAS391 with pHD957 resulted
in a 4.3-fold decrease in biofilm mass as compared to
the parent UAS391 (P < 0.0001).
Discussion
By comparing the whole genome sequences of closely
related USA300 strains that strongly differed in their
capacity to form biofilms in a dynamic flow model, iden-
tified genetic differences (SNPs) were hypothesized to be
responsible for this altered biofilm phenotype. Seventeen
transposon mutants knocked out in these genes in the
USA300-JE2 background (NARSA strains) were evalu-
ated for the degree of biofilm formation in comparison
to the parent JE2. Transposon-mediated interruption of
one of the tested divergent genes, fakA [25], previously
known as vfrB [26], resulted in a 4.6-fold increase in bio-
film formation as compared to the parental control
strain JE2. In the other USA300 strains, UAS391 and
TCH1516, the fakA::Tn mutations also led to increased
biofilm formation, and further complementation experi-
ments confirmed the role of fakA in the regulation of
biofilm formation.
Running the protein sequence of SAUSA300_1119 in
Simple Modular Architecture Research Tool (SMART)
identified two domains within the protein sequence: Dak2
encoding the predicted phosphatase domain of the dihy-
droxyacetone kinase family (35 to 200 nt), and Dak1_2 en-
coding the kinase domain of the dihydroxyacetone kinase
family (236 nt to 548 nt). The glutamic acid to glycine
change is located at position 524 of the protein corre-
sponding to its kinase domain. These proteins, collectively
called Dak2 domain proteins have homologues in a wide
variety of bacteria. Transposon insertions in fakA were
first isolated in a large S. aureus transposon (bursa aurea-
lis-bearing) insertion mutants library screen based on an
increased resistance to an antimicrobial peptide [27]. Im-
portantly, this fakA (then called dak2) mutant exhibited
an altered membrane phospholipid composition com-
pared to its wild-type parent [27]. Recent studies have fur-
ther delineated the multiple functions of fakA as an
important regulator of virulence factors [26] and as a fatty
acid kinase responsible for host fatty acid incorporation by
S. aureus [25]. Interestingly, in the present study, comple-
mentation by the fakA allele of TCH1516, which is the
consensus allele, in the fakA::Tn NE229 and in the
UAS391 strains decreased the amount of biofilm forma-
tion by 2.7- and 4.3-fold, respectively, to the level observed
in the JE2 wild-type strain. However, similar complemen-
tation by the UAS391 fakA allele, which harbours the glu-
tamic acid to glycine change, did not affect biofilmformation in fakA::Tn NE229. Taken together, these re-
sults imply that the mutation in the UAS391 fakA might
have impacted the catalytic activity of the kinase, and
whether UAS391 exhibits an altered membrane phospho-
lipid composition due to this amino acid change, which
increased its biofilm forming ability, remains to be
studied.
Interestingly, microarray-based gene expression data from
a USA300 fakA::Tn mutant showed significant up-regulation
of 26 and down-regulation of 19 genes [25]. The down-
regulated genes included saeP and saeQ that are part of
the saeRS two-component regulatory system and are
known to regulate the activity of the saeS-encoded sensor
histidine kinase [28]. The saeRS system was also recently
shown to be a negative regulator of biofilm formation in
S. aureus [29]. This study showed that a S. aureus New-
man ΔsaeRS strain exhibited an enhanced biofilm pheno-
type, similar to the fakA::Tn JE2-NE229 mutant and the
UAS391 wild-type strains in our study. Taken together,
these phenotypic and gene expression data strongly sug-
gest a potential interaction between fakA and saeRS in
negatively regulating biofilm formation in S. aureus. Fi-
nally, mice infected with vfrB::Tn (fakA::Tn) S. aureus
have been shown to develop significantly larger abscess
areas and dermonecrosis [26], which also reflects the in-
creased biofilm abundance observed for the fakA::Tn mu-
tant in our study.
Thus utilizing a combination of functional assays and
genomics, we identified fakA, a known virulence factor
regulator and a fatty acid kinase, as an important nega-
tive regulator of biofilm formation in S. aureus USA300.
Conclusions
The sequential approach used here, starting from comparing
clonally related (as per optical mapping) clinical isolates with
different clinically relevant phenotypes, then comparing the
respective total genome information allowed to pinpoint a
gene locus, that is clearly of relevance for biofilm formation
in S. aureus.
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